Aytu BioPharma (NASDAQ:AYTU) Stock Price Crosses Below 50-Day Moving Average – Here’s Why

Aytu BioPharma, Inc. (NASDAQ:AYTU)’s share price crossed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $1.59 and traded as low as $1.34. Aytu BioPharma shares last traded at $1.35, with a volume of 64,208 shares traded.

Aytu BioPharma Stock Down 2.2 %

The company has a market capitalization of $8.33 million, a PE ratio of -0.93 and a beta of -1.45. The company has a quick ratio of 0.81, a current ratio of 0.98 and a debt-to-equity ratio of 0.32. The firm has a 50-day moving average of $1.59 and a two-hundred day moving average of $1.95.

Aytu BioPharma (NASDAQ:AYTU) last issued its quarterly earnings data on Wednesday, February 12th. The company reported ($0.28) earnings per share for the quarter. Aytu BioPharma had a negative return on equity of 19.30% and a negative net margin of 7.62%.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Aytu BioPharma stock. Stonepine Capital Management LLC raised its position in shares of Aytu BioPharma, Inc. (NASDAQ:AYTU) by 6.0% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 500,958 shares of the company’s stock after buying an additional 28,489 shares during the period. Aytu BioPharma comprises about 0.7% of Stonepine Capital Management LLC’s holdings, making the stock its 25th largest holding. Stonepine Capital Management LLC owned about 8.15% of Aytu BioPharma worth $1,177,000 at the end of the most recent reporting period. Hedge funds and other institutional investors own 33.49% of the company’s stock.

Aytu BioPharma Company Profile

Aytu Biopharma, Inc is a specialty pharmaceutical company, which engages in identifying, acquiring, and commercializing novel products. It operates through the Rx and Consumer Health segments. The RX segment consists of various prescription pharmaceutical products sold through third parties. The Consumer Health segment includes various consumer health products sold directly to consumers.